[{"Assets_0_Q2_USD":2530950000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-52599000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":559541253.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":559507732.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":559541253.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":559507732.0,"EarningsPerShareBasic_1_Q2_USD":-0.01,"EarningsPerShareBasic_2_Q2_USD":-0.09,"EarningsPerShareDiluted_1_Q2_USD":-0.01,"EarningsPerShareDiluted_2_Q2_USD":-0.09,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":263685000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":518598000.0,"Ticker":"OPK","CIK":"944809","name":"OPKO HEALTH, INC.","OfficialName":"OPKO Health Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2187471532.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]